tiprankstipranks
Reneo Pharmaceuticals (RPHM)
NASDAQ:RPHM
US Market

Reneo Pharmaceuticals (RPHM) Financial Statements

226 Followers

Reneo Pharmaceuticals Financial Overview

Reneo Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.171; its P/E ratio is -0.71; Reneo Pharmaceuticals is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.13. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -9.56M$ -20.89M$ -19.53M$ -15.11M$ -13.60M
EBITDA$ -9.55M$ -20.84M$ -20.61M$ -15.72M$ -14.12M
Net Income Common Stockholders$ -8.43M$ -19.20M$ -19.50M$ -15.11M$ -13.60M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 82.83M$ 125.61M$ 142.68M$ 93.79M$ 101.17M
Total Assets$ 84.64M$ 130.39M$ 148.04M$ 98.29M$ 108.18M
Total Debt$ 907.00K$ 1.14M$ 1.22M$ 1.34M$ 1.46M
Net Debt$ -81.93M$ -124.48M$ -141.46M$ -92.44M$ -99.71M
Total Liabilities$ 3.40M$ 15.44M$ 15.51M$ 11.78M$ 8.21M
Stockholders Equity$ 81.24M$ 114.94M$ 132.53M$ 87.08M$ 99.97M
Cash Flow-
Free Cash Flow$ -21.01M$ -18.79M$ -16.12M$ -9.22M$ -15.86M
Operating Cash Flow$ -21.01M$ -18.77M$ -16.11M$ -9.05M$ -15.61M
Investing Cash Flow$ 13.76M$ 21.25M$ -69.01M$ 18.51M$ -26.92M
Financing Cash Flow-$ 173.00K$ 63.81M$ 1.01M$ 325.00K
Currency in USD

Reneo Pharmaceuticals Earnings and Revenue History

Reneo Pharmaceuticals Debt to Assets

Reneo Pharmaceuticals Cash Flow

Reneo Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis